603567.SS
Price:
$10.72
Market Cap:
$10.06B
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-04-24
Stock Exchange
SHH
Ticker
603567.SS
According to Heilongjiang ZBD Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 5.08%. This represents a change of 304.93% compared to the average of 1.25% of the last 4 quarters.
The mean historical ROE of Heilongjiang ZBD Pharmaceutical Co., Ltd. over the last ten years is 9.81%. The current 5.08% ROE has changed -48.23% with respect to the historical average. Over the past ten years (40 quarters), 603567.SS's ROE was at its highest in in the December 2014 quarter at 9.45%. The ROE was at its lowest in in the September 2022 quarter at -1.18%.
Average
9.81%
Median
8.62%
Minimum
2.61%
Maximum
21.81%
Discovering the peaks and valleys of Heilongjiang ZBD Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 139.75%
Maximum Annual ROE = 21.81%
Minimum Annual Increase = -44.60%
Minimum Annual ROE = 2.61%
Year | ROE | Change |
---|---|---|
2023 | 6.26% | 139.75% |
2022 | 2.61% | -44.60% |
2021 | 4.72% | -40.62% |
2020 | 7.94% | 1.86% |
2019 | 7.80% | -16.18% |
2018 | 9.30% | -16.63% |
2017 | 11.15% | -5.84% |
2016 | 11.85% | -18.98% |
2015 | 14.62% | -32.96% |
2014 | 21.81% | -12.66% |
The current ROE of Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.53%
5-year avg
5.87%
10-year avg
9.81%
Heilongjiang ZBD Pharmaceutical Co., Ltd.’s ROE is less than Hubei Jumpcan Pharmaceutical Co., Ltd. (14.81%), greater than Shandong Buchang Pharmaceuticals Co., Ltd. (-2.57%), less than Zhejiang Weiming Environment Protection Co., Ltd. (20.84%), less than LBX Pharmacy Chain Joint Stock Company (12.24%), less than Tasly Pharmaceutical Group Co., Ltd (7.95%),
Company | ROE | Market cap |
---|---|---|
14.81% | $24.09B | |
-2.57% | $16.75B | |
20.84% | $32.88B | |
12.24% | $15.27B | |
7.95% | $22.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heilongjiang ZBD Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Heilongjiang ZBD Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Heilongjiang ZBD Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)?
What is the highest ROE for Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)?
What is the 3-year average ROE for Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)?
What is the 5-year average ROE for Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)?
How does the current ROE for Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS) compare to its historical average?